Table 2 Demographic characteristics of antiretroviral-naïve HIV+ patients initiating atazanavir-containing vs. atazanavir-free regimens

From: Risk of cardiovascular events among patients with HIV treated with atazanavir-containing regimens: a retrospective cohort study

	Commercial Database					Medicaid Database
	ATV-Containing Regimen N = 2,437		ATV-Free Regimen N = 19,774		p-value	ATV-Containing Regimen N = 1,505		ATV-Free Regimen N = 5,631		p-value
	N	%	N	%		N	%	N	%
Age in Years (Mean, SD)	41.0	10.2	40.4	10.5	0.0055	41.2	10.9	41.3	11.2	0.6919
Male	1,863	76.4 %	16,566	83.8 %	<.0001	746	49.6 %	2,883	51.2 %	0.2282
Region^a
Northeast	439	18.0 %	3,146	15.9 %	0.0002
North Central	290	11.9 %	2,896	14.6 %
South	1,229	50.4 %	10,174	51.5 %
West	440	18.1 %	3,300	16.7 %
Unknown	39	1.6 %	258	1.3 %
Race^b
White						206	13.7 %	964	17.1 %	0.0153
Black						1,088	72.3 %	3,894	69.2 %
Hispanic						16	1.1 %	76	1.3 %
Other						13	0.9 %	62	1.1 %
Unknown/Missing						182	12.1 %	635	11.3 %
Capitation^c	548	22.5 %	3,754	19.0 %	<.0001	609	40.5 %	2,256	40.1 %	0.7779

ATV atazanavir, SD standard deviation
^aCommercial population only; ^bMedicaid population only; ^cPresence of claim with capitated payment arrangement

Back to article page